vaccines
Vaccines that prevent infectious diseases.
Industry · 3 companies · 2 report it as a revenue line
MRK Merck & Co.
Sells it 16%, $10.1B a year“Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines.”
- Revenue$65.0BYoY +1.3%
- Net income$18.3BYoY +6.6%
- Revenue$18.1BYoY +4.7%
- Net income$5.1BYoY −12.4%
- Revenue$1.3BYoY +29.2%
- Net income$162.0Mvs −$200.0M year ago
PFE Pfizer
Sells it, part of Product“Vaccines product portfolio across all ages – select products include: the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix and Trumenba.”
- Revenue$62.6BYoY −1.6%
- Net income$7.8BYoY −3.2%
- Revenue$16.6BYoY −0.4%
- Net income$3.2BYoY −8.4%
No companies have a recent 8-K matching these events.
No companies in the selected roles.